Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 676 of 6351
-
Can a novel pacemaker strategy tame stubborn atrial fibrillation?
Disease control Recruiting nowThis study aimed to compare the clinical outcomes of left bundle branch area pacing combined with atrioventricular node ablation and pharmacologic treatment optimized according to guidelines in patients with symptomatic atrial fibrillation refractory or intolerant to drug therapy…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New Clot-Busting device could offer quick relief for lung blockages
Disease control PausedThis study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subjects with acute pulmonary embolism (PE).
Sponsor: Akura Medical • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New combo therapy aims to ease strain on heart in rare lung condition
Disease control Stopped earlyThe main goal of this study is to determine the effects of combination medical therapy (Riociguat and Macitentan) and balloon pulmonary angioplasty (BPA) on hemodynamics and right ventricular (RV) function (including advanced assessments of RV-pulmonary artery (PA) coupling from …
Phase 3 • Sponsor: Dr Sudarshan Rajagopal • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Allergy pill tested to protect heart attack survivors
Disease control Recruiting nowThe goal of this study is o evaluate the prognostic effect of fexofenadine hydrochloride in patients with myocardial infarction
Phase 3 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Ketamine showdown: IV drip vs nasal spray for depression
Symptom relief Recruiting nowThe purpose of this study is to compare the relative effectiveness, acceptability, and side effects of ketamine delivered through an IV (a drip into the arm) which is not currently FDA approved for use in the treatment of treatment-resistant depression (TRD) and Esketamine (Sprav…
Phase 3 • Sponsor: Yale University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New drug cocktail aims to tackle tough sarcomas in young patients
Disease control Recruiting nowThis research is being done to test a new drug called PEEL-224 in combination with two commercially available drugs, Vincristine and Temozolomide, and to determine how effective this combination of drugs is at treating Ewing Sarcoma (EWS) and Desmoplastic Small Round Cell Tumor (…
Phase 1/2 • Sponsor: David S Shulman, MD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a 6-Hour course cut suicide risk in the air force?
Prevention By invitation onlyThis trial tests the effectiveness of the Wingman-Connect Program delivered by USAF personnel on individual suicide risk. Randomization will be among classes at Initial Technical Training, in which 396 classes of USAF personnel will be randomized to Wingman-Connect or to an activ…
Sponsor: University of Rochester • Aim: Prevention
Last updated Jun 27, 2026 11:04 UTC
-
A jolt to the brain may unlock words: testing tDCS for language in down syndrome
Symptom relief Recruiting nowDown syndrome (DS) is associated with cognitive deficits, caused by alterations in neuroplasticity and synaptic transmission. Non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS), can modulate the brain's plasticity mechanisms and neur…
Sponsor: Floriana Costanzo • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Sound waves vs. dystonia: could a No-Cut brain treatment end limb twisting?
Disease control Recruiting nowThe goal of this clinical trial is to find out if a non-invasive procedure called focused ultrasound can safely and effectively treat limb dystonia in adults who have not improved with medications or botulinum toxin injections. The main questions it aims to answer are: * Does f…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug HLX43 targets tough esophageal cancers
Disease control Recruiting nowThe study is being conducted to explore the reasonable dosage and evaluate the efficacy, safety and tolerability of HLX43 (Anti-PD-L1 ADC) in Patients with Recurrent/Metastatic Esophageal Squamous Cell Carcinomar (ESCC) Failed or Intolerance to Standard First-Line Therapy.
Phase 2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a targeted nerve block cut opioid use in High-Risk C-Sections?
Symptom relief CompletedDue to the significant risk of massive bleeding complicated by profound hypotension and coagulopathy and a high likelihood of hysterectomy during caesarean delivery, general anesthesia is generally regarded as the anesthetic of choice for patients with placenta accreta. The advan…
Sponsor: Kasr El Aini Hospital • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Promising cream may help kids with vitiligo regain skin color
Disease control Recruiting nowThe purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Smart scans and DNA tests could tailor lymphoma therapy, reducing chemo for some
Disease control Recruiting nowThis is a phase ll study of participants with untreated diffuse large B Cell lymphoma (DLBCL).
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stem cell protocol offers hope for older adults with aplastic anemia
Disease control Recruiting nowOutcomes for adult patients with Severe Aplastic Anemia (SAA) aged more than 40 years who are refractory or in relapse after first-line IST remain poor. Hematopoietic stem cell transplantation (HSCT) is the unic valid therapeutic option but results have always been disappointing …
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New daily pill shows promise for weight loss in obesity trial
Disease control CompletedThis is a phase 2, 36-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the safety, tolerability, weight loss efficacy, pharmacodynamic effects, and pharmacokinetics of RGT001-075 in adults who are obese (BMI ≥30 kg/m²) or who are overweight…
Phase 2 • Sponsor: Regor Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a night of soft sounds sharpen the epileptic brain?
Knowledge-focused Recruiting nowFocal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo two nights of testing (at least one week apart) at California Sleep Solutions (CSS) in Sacramento, CA.…
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New hope for head and neck cancer: Triple-Drug combo tested after immunotherapy fails
Disease control Recruiting nowThis study targets an adult population of patients with recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC), who have failed after a first line of treatment with pembrolizumab associated or not with chemotherapy and having an indication for a second line o…
Phase 2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for young cancer patients: drug combo targets relapsed solid tumors
Disease control Recruiting nowThe aim of this clinical study is to determine the efficacy and safety of the liposomal mitoxantrone combination regimen in treating relapsed and refractory solid tumors among children, adolescents, and young adults. The key questions it intends to address are: Can the liposomal…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for Hard-to-Treat prostate cancer? early trial launches
Disease control Recruiting nowThis is a Phase 1 and Phase 2 study to evaluate the safety and antitumor activity of INV-9956 in adult patients with advanced metastatic Castration Resistant Prostate Cancer.
Phase 1/2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New vein procedure could help millions who feel faint when standing
Disease control Recruiting nowOrthostatic hypotension (OH) and orthostatic intolerance (OI) are common conditions where blood pressure drops when standing up, causing dizziness, fainting, or fatigue. These affect up to 30% of adults over 65 and raise risks for heart disease, stroke, kidney problems, and more.…
Sponsor: St. Francis Hospital, New York • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC